Salivary Biomarkers for Detection of Oral Squamous Cell Carcinoma: Current State and Recent Advances

被引：2
作者：
Yakob M. [1 ]
Fuentes L. [1 ]
Wang M.B. [2 ]
Abemayor E. [2 ]
Wong D.T.W. [1 ]
机构：
[1] Center for Oral/Head & Neck Oncology Research, School of Dentistry, University of California, Los Angeles, 73-017 CHS, 10833 Le Conte Avenue, Los Angeles, 90095, CA
[2] Department of Head and Neck Surgery, David Geffen School of Medicine at University of California Los Angeles, Los Angeles, CA
来源：
Current Oral Health Reports | 2014年 / 1卷 / 2期
基金：
美国国家卫生研究院;
关键词：
Exosomes; Metabolomics; Methylomics; Microbiomics; Oral cancer; Oral fluid diagnostics; Oral squamous cell carcinoma; Proteomics; Salivaomics; Salivary biomarker; Salivary diagnostics; Transcriptomics;
D O I：
10.1007/s40496-014-0014-y
中图分类号：
学科分类号：
摘要：
Oral squamous cell carcinoma (OSCC) is the most common malignant neoplasm of the oral cavity. Detection of OSCC is currently based on a thorough clinical oral examination combined with a biopsy for histological analysis. Most cases of OSCC are not detected until the cancer has developed into advanced stages; thus, a reliable early-stage diagnostic marker is needed. This literature review presents an overview of the status of current advances in salivary diagnostics for OSCC. Though many protein and mRNA salivary biomarkers have been identified that can detect OSCC with high sensitivity and specificity, the most discernable findings occur with the use of multiple markers. Studies that incorporate proteomic, transcriptomic, and potentially additional “omics”, including methylomics, need to be initiated to bring technology to clinical applications and allow the best use of saliva in diagnosing OSCC. © 2014, Springer International Publishing AG.
引用
收藏
页码：133 / 141
页数：8
相关论文
共 97 条
[31]  
Xiao H., Zhang L., Zhou H., Lee J.M., Garon E.B., Wong D.T.W., Proteomic analysis of human saliva from lung cancer patients using two-dimensional difference gel electrophoresis and mass spectrometry, Mol Cell Proteomics, 11, 2, (2012)
[32]  
Gao K., Zhou H., Zhang L., Lee J.W., Zhou Q., Hu S., Et al., Systemic disease-induced salivary biomarker profiles in mouse models of melanoma and non-small cell lung cancer, PLoS One, 4, 6, (2009)
[33]  
Hu S., Gao K., Pollard R., Arellano-Garcia M., Zhou H., Zhang L., Et al., Preclinical validation of salivary biomarkers for primary Sjögren's syndrome, Arthritis Care Res, 62, 11, pp. 1633-1638, (2010)
[34]  
Sugimoto M., Wong D.T., Hirayama A., Soga T., Tomita M., Capillary electrophoresis mass spectrometry-based saliva metabolomics identified oral, breast and pancreatic cancer-specific profiles, Metabolomics, 6, 1, pp. 78-95, (2010)
[35]  
Lau C., Kim Y., Chia D., Spielmann N., Eibl G., Elashoff D., Et al., Role of pancreatic cancer-derived exosomes in salivary biomarker development, J Biol Chem, 288, 37, pp. 26888-26897, (2013)
[36]  
Ilyin S.E., Belkowski S.M., Plata-Salaman C.R., Biomarker discovery and validation: technologies and integrative approaches, Trends Biotechnol, 22, 8, pp. 411-416, (2004)
[37]  
Silberring J., Ciborowski P., Biomarker discovery and clinical proteomics, Trends Anal Chem, 29, 2, pp. 128-140, (2010)
[38]  
Chen W., Samuelson F.W., Gallas B.D., Kang L., Sahiner B., Petrick N., On the assessment of the added value of new predictive biomarkers, BMC Med Res Methodol, 13, (2013)
[39]  
Warnock D.G., Peck C.C., A roadmap for biomarker qualification, Nat Biotechnol, 28, 5, pp. 444-445, (2010)
[40]  
Bryne M., Koppang H.S., Lilleng R., Kjaerheim A., Malignancy grading of the deep invasive margins of oral squamous cell carcinomas has high prognostic value, J Pathol, 166, 4, pp. 375-381, (1992)
12345678910